Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Calcium carbonate; Sodium alginate; Sodium bicarbonate
Pinewood Healthcare
A02BX13
Calcium carbonate; Sodium alginate; Sodium bicarbonate
16mg/1ml ; 50mg/1ml ; 26.7mg/1ml
Oral suspension
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 01010201; GTIN: 5099186003399 5099186005256
250 ML P 250 ML P Each 10 ml of the oral suspension contains 1000 mg of sodium alginate and 200 mg of potassium hydrogen carbonate. Also contains parahydroxybenzoates (Parabens, E214 and E216) which may cause allergic reactions (possibly delayed). This medicinal product contains about 5.1 mmol of sodium and 2 mmol of potassium per 10 ml dose. To be taken into consideration by patients on a controlled sodium diet or when taking drugs which can increase potassium levels. Care should also be taken if on calcium controlled diet. Read the attached leaflet carefully before use. To be taken by mouth after meals and at bedtime. Shake bottle well before use. Keep out of the sight and reach of children. Take special care if you are allergic to any of the ingredients of this medicine. Side effects are occasional. See leaflet for further information. Store below 25ºC. Do not use after the expiry date shown on the label. Do not refrigerate or freeze MA HOLDER: Wockhardt UK Ltd, Ash Road North, Wrexham, LL13 9UF, UK. PL 29831/0698 23LL05557PW 108173/3 _ACIDEX_ _ _ _ _ _ _ _ADVANCE_ _ACIDEX_ _ _ _ _ _ _ _ADVANCE_ _ORAL SUSPENSION_ _ORAL SUSPENSION_ (PEPPERMINT FLAVOUR) SODIUM ALGINATE, POTASSIUM HYDROGEN CARBONATE _HEARTBURN AND_ _INDIGESTION SUSPENSION_ _ACIDEX_ _ _ _ _ _ _ _ADVANCE_ _ACIDEX_ _ _ _ _ _ _ _ADVANCE_ _ORAL SUSPENSION_ _ORAL SUSPENSION_ (PEPPERMINT FLAVOUR) SODIUM ALGINATE, POTASSIUM HYDROGEN CARBONATE _HEARTBURN AND_ _INDIGESTION SUSPENSION_ Each 10 ml of the oral suspension contains 1000 mg of sodium alginate and 200 mg of potassium hydrogen carbonate. Also contains parahydroxybenzoates (Parabens, E214 and E216) which may cause allergic reactions (possibly delayed). This medicinal product contains about 5.1 mmol of sodium and 2 mmol of potassium per 10 ml dose. To be taken into consideration by patients on a controlled sodium diet or when taking drugs which can increase potassium levels. Care should also be taken if on calcium controlled diet. Read the attached leaflet carefully before use. To be taken by mouth Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Acidex Oral Suspension LloydsPharmacy Heartburn and Indigestion Liquid Peppermint Flavoured Boots Heartburn Relief Peppermint Flavour Peptac Peppermint Liquid Tesco Heartburn & Indigestion relief Heartburn and Indigestion Oral Suspension Peppermint Flavour Healthpoint Heartburn and Indigestion Oral Suspension Rennie Liquid Heartburn Relief Oral Suspension Well Pharmaceuticals Heartburn & Indigestion Peppermint Flavour Oral Suspension 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each 5ml contains: Sodium Bicarbonate PhEur - 133.5mg Sodium Alginate PhEur - 250mg Calcium Carbonate PhEur - 80mg 3 PHARMACEUTICAL FORM Oral Suspension Peppermint Flavoured White Suspension Gluten and Sugar free 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Acidex alleviates the painful conditions resulting from the reflux of gastric acid and bile into the oesophagus by suppressing the reflux itself. It is indicated in heartburn, including heartburn of pregnancy, dyspepsia associated with gastric reflux, hiatus hernia, reflux oesophagitis, regurgitation and all cases of epigastric and retrosternal distress where the underlying cause is gastric reflux. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION For oral use Adults and children over 12 years: Two to four 5ml spoonfuls Children 6 -12 years: One to two 5ml spoonfuls Not recommended in children under six years of age. Doses should be taken after meals and at bedtime. 4.3 CONTRAINDICATIONS This medicinal product is contraindicated in patients with known or suspected hypersensitivity to the active substances or to any of the excipients listed in section 6.1, including methyl parahydroxybenzoate (E218) and propyl parahydroxybenzoate (E216) (see section 4.4). 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE If symptoms do not improve after seven days, the clinical situation should be reviewed. Each 10 ml dose of Acidex contains about 6 mmoles of sodium and therefore care should be exercised in patients on a sodium restricted diet. Ea Read the complete document